SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors
Authors
Keywords
-
Journal
Science Signaling
Volume 11, Issue 515, Pages eaan0949
Publisher
American Association for the Advancement of Science (AAAS)
Online
2018-01-31
DOI
10.1126/scisignal.aan0949
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteomic and histopathological characterization of the interface between oral squamous cell carcinoma invasion fronts and non-cancerous epithelia
- (2017) Tatsuya Abé et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Basement membrane protein ladinin-1 and the MIF-CD44-β1 integrin signaling axis are implicated in laryngeal cancer metastasis
- (2016) Marko Klobučar et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets
- (2016) Xiaosheng Wang et al. MEDICINE
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
- (2016) Bernard Pereira et al. Nature Communications
- A Structural Perspective on the Regulation of the Epidermal Growth Factor Receptor
- (2015) Erika Kovacs et al. Annual Review of Biochemistry
- 14-3-3ζ Turns TGF-β’s Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p53 to Gli2
- (2015) Jia Xu et al. CANCER CELL
- Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression
- (2015) H. Cohen-Dvashi et al. EMBO Molecular Medicine
- Filamin A: Insights into its Exact Role in Cancers
- (2015) Qian-Qian Shao et al. PATHOLOGY & ONCOLOGY RESEARCH
- Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
- (2015) Nir Ben-Chetrit et al. Science Signaling
- Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
- (2015) Nir Ben-Chetrit et al. Science Signaling
- BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma
- (2015) Dagmara Rusinek et al. PLoS One
- Shaping up to divide: Coordinating actin and microtubule cytoskeletal remodelling during mitosis
- (2014) Oscar M. Lancaster et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- A new genome-driven integrated classification of breast cancer and its implications
- (2013) Sarah-Jane Dawson et al. EMBO JOURNAL
- Integrating actin dynamics, mechanotransduction and integrin activation: The multiple functions of actin binding proteins in focal adhesions
- (2013) Corina Ciobanasu et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- The shaping and functional consequences of the microRNA landscape in breast cancer
- (2013) Heidi Dvinge et al. NATURE
- High-throughput chromatin immunoprecipitation for genome-wide mapping of in vivo protein-DNA interactions and epigenomic states
- (2013) Ronnie Blecher-Gonen et al. Nature Protocols
- 14-3-3 stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion
- (2013) A. Boudreau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential expression of filamin A and its clinical significance in breast cancer
- (2013) HUI-MIN TIAN et al. Oncology Letters
- Cell migration and invasion in human disease: the Tks adaptor proteins
- (2012) Sara A. Courtneidge BIOCHEMICAL SOCIETY TRANSACTIONS
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Targeting filamin A reduces K-RAS–induced lung adenocarcinomas and endothelial response to tumor growth in mice
- (2012) Rajesh K Nallapalli et al. Molecular Cancer
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- Life at the Leading Edge
- (2011) Anne J. Ridley CELL
- EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF
- (2011) Gabi Tarcic et al. FASEB JOURNAL
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
- (2011) Jürgen Cox et al. JOURNAL OF PROTEOME RESEARCH
- Two Phases of Mitogenic Signaling Unveil Roles for p53 and EGR1 in Elimination of Inconsistent Growth Signals
- (2011) Yaara Zwang et al. MOLECULAR CELL
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Filamin a mediates HGF/c-MET signaling in tumor cell migration
- (2010) Alex-Xianghua Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roles for Growth Factors in Cancer Progression
- (2010) Esther Witsch et al. PHYSIOLOGY
- GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
- (2009) Eran Eden et al. BMC BIOINFORMATICS
- ErbB receptors and signaling pathways in cancer
- (2009) Nancy E Hynes et al. CURRENT OPINION IN CELL BIOLOGY
- Crosstalk in Met receptor oncogenesis
- (2009) Andrea Z. Lai et al. TRENDS IN CELL BIOLOGY
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation